SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-010974
Filing Date
2018-08-09
Accepted
2018-08-09 17:08:36
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20180630-10q.htm 10-Q 933791
2 EXHIBIT 10.1 ex-101xazletteragreement.htm EX-10.1 7183
3 EXHIBIT 31.1 ex-311x20180630.htm EX-31.1 12037
4 EXHIBIT 31.2 ex-312x20180630.htm EX-31.2 12065
5 EXHIBIT 32.1 ex-321x20180630.htm EX-32.1 11828
  Complete submission text file 0001628280-18-010974.txt   4318279

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgls-20180630.xml EX-101.INS 849976
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20180630.xsd EX-101.SCH 31117
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20180630_cal.xml EX-101.CAL 50877
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20180630_def.xml EX-101.DEF 166938
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20180630_lab.xml EX-101.LAB 444319
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20180630_pre.xml EX-101.PRE 253671
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 181006254
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences